WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 5801 Infant (under 12 months) mortality rate: 522
GDP / capita (US$): 1'4541 Child (under 5 years) mortality rate: 782

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 7'305  7'115  6'929  6'746  6'566  4'875  3'787  2'721 
Births 256  253  250  247  244  194  161  130 
Surviving infants 245  241  238  234  231  179  147  117 
Pop. less than 5 years 1'160  1'142  1'125  1'107  1'088  817  684  517 
Pop. less than 15 years 3'085  3'019  2'950  2'880  2'809  2'161  1'751  1'263 
Female 15-49 years 1'785  1'736  1'689  1'644  1'601  1'162  845  597 

Number of reported cases

(Click for retrospective incidence data for Togo)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  20  577  564  238  187  3'578  4'548  33'960 
Mumps
ChartChart
 
Pertussis
ChartChart
  23  38  30  32  34  115  431  3'901 
Polio*
ChartChart
  20  178 
Rubella
ChartChart
  16  38  33  69 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  12  18  26  20  28  33  42  217 
Tetanus (total)**
ChartChart
  12  18  26  20  28  107  436 
Yellow fever
ChartChart
  12 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Togo)
Vaccine year result method % card seen                                                
BCG 2013  95  DHS   70  86  79  97  97  90  83  99* 
DTP1 2013  93  DHS   70  92  91  94  94  95  66 
DTP3 2013  83  DHS   70  88  87  84  84  92  50  77 
DTP4         
IPV1         
HepB_BD         
HepB3 2013  83  DHS   70  88  87  84  84  92 
Hib3 2013  83  DHS   70  88  87  84  84  92 
JapEnc         
MCV1          85  82  72  72  85  43  65 
MCV2         
PCV1          91  42 
PCV3          86  34 
Pol3 2013  74  DHS   70  88  85  84  84  92  50  78 
Rota1          90  35 
RotaC          85  35 
Rubella1         
TT2plus 2013  62  DHS   70  78  80  78  78  86  47  35 
PAB         
VAD1          99  89  91 
YFV 2013  73  DHS   70  85  82  72  72  85 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Togo)
BCG
ChartChart
  97  97  97  97  84  99 
DTP1
ChartChart
  91  94  94  94  80  90 
DTP3
ChartChart
  87  84  84  85  64  77 
HepB3
ChartChart
  87  84  84  85 
HepB_BD
ChartChart
 
Hib3
ChartChart
  87  84  84  85 
MCV1
ChartChart
  82  72  72  72  58  73 
MCV2
ChartChart
 
PAB
ChartChart
  81  77  81  81  63  47 
PCV3
ChartChart
  34 
Pol3
ChartChart
  85  84  84  85  63  76 
RotaC
ChartChart
  35 
YFV
ChartChart
  82  72  72  72 

Number of districts in the country 40  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 45
From 80 to 89% 40
From 50 to 79% 15
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 10 years; No
IPV 14 weeks; Yes From September 2016
MR 9 months; Yes From November 2017
Measles 9 months; Yes
MenA Yes From July 2017
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 9 months; Yes and post-partum women
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011 - 2015  2011 - 2015  2007 - 2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 40  40  35  35  35  35  35 

System performance

Total Nº districts in country number 40  40  35  35  35  35  35 
Nº districts with DTP3 coverage >=80% number 34  37  33  30  31  29  30 
% of districts with DTP3 coverage >=80% From 0 to 100% 85  93  94  86  89  83  86 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 10  20  23  20  26  14 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 25  55  51  45  46  17 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.